17-15239584-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 11P and 4B. PVS1PS1_ModeratePP5BS2
The ENST00000494511.7(PMP22):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000494511.7 start_lost
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 1AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine, Ambry Genetics
- hereditary neuropathy with liability to pressure palsiesInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- Charcot-Marie-Tooth disease type 1EInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth disease type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PMP22 | NM_000304.4 | c.206T>C | p.Met69Thr | missense_variant | Exon 4 of 5 | ENST00000312280.9 | NP_000295.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152264Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461654Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727132 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152264Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74390 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Dejerine-Sottas disease;C0270911:Charcot-Marie-Tooth disease, type IA Pathogenic:1
ACMG Criteria: PM1, PM2_P, PM5, PP3, PP5 ; Variant was found in heterozygous state. -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Charcot-Marie-Tooth disease, type I Pathogenic:1
This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 69 of the PMP22 protein (p.Met69Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PMP22-related conditions. ClinVar contains an entry for this variant (Variation ID: 531685). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PMP22 protein function with a positive predictive value of 95%. This variant disrupts the p.Met69 amino acid residue in PMP22. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8275092, 26102530). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Inborn genetic diseases Uncertain:1
The p.M69T variant (also known as c.206T>C), located in coding exon 3 of the PMP22 gene, results from a T to C substitution at nucleotide position 206. The methionine at codon 69 is replaced by threonine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at